2021. Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland. Swiss Medical Weekly. 151, 0304 (Jan. 2021), w20399. DOI:https://doi.org/10.4414/smw.2021.20399.